Back
Entrada Therapeutics Stock Predictions
Sponsored
TRDA
Sponsored
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Buy
64
TRDA
Entrada Therapeutics
Last Price:
19.01
Seasonality Move:
-34.31%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE TradeEntrada Therapeutics Stock Forecast
- Over the next 52 weeks, Entrada Therapeutics has on average historically fallen by 7.2% based on the past 3 years of stock performance.
- Entrada Therapeutics has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Entrada Therapeutics Stock Undervalued?
The current Entrada Therapeutics [TRDA] share price is $18.62. The Score for TRDA is 64, which is 28% above its historic median score of 50, and infers lower risk than normal. - TRDA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Entrada Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Entrada Therapeutics has on average historically fallen by 7.2% based on the past 3 years of stock performance.
Entrada Therapeutics Stock Rating
Buy
64
Entrada Therapeutics (TRDA)
is a Buy
Is Entrada Therapeutics overpriced?
- Entrada Therapeutics has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Entrada Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
entradatx.com
52-Week Data
52-Week High:
18.62
52-Week Low:
10.75
Prediction Charts
Market Cap:
692.66M
Price in USD:
18.62
Volume:
153.69K
Beta:
-0.26
Technical Analysis
SMA50:
16.25
SMA100:
15.98
SMA200:
14.96
52-Wk Change:
11.83%
Stock Predictions
-
Is Entrada Therapeutics stock public?
Yes, Entrada Therapeutics is a publicly traded company. -
What is the Entrada Therapeutics stock quote today?
The Entrada Therapeutics stock price is 18.62 USD today. -
How to buy Entrada Therapeutics stock online?
You can buy Entrada Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-16 | 17.78 | 17.66 | 18.01 | 17.54 |
Oct-18 | 17.73 | 17.44 | 17.80 | 17.31 |
Oct-21 | 17.35 | 17.32 | 17.49 | 16.80 |
Oct-22 | 17.19 | 17.13 | 17.52 | 16.89 |
Oct-23 | 17.00 | 16.97 | 17.17 | 16.81 |
Oct-24 | 17.00 | 16.84 | 17.42 | 16.81 |
Oct-25 | 17.01 | 16.99 | 17.74 | 16.99 |
Oct-28 | 17.17 | 17.37 | 17.75 | 17.17 |
Oct-29 | 17.41 | 17.29 | 17.64 | 16.96 |
Oct-30 | 17.25 | 17.23 | 17.54 | 17.08 |
Oct-31 | 17.25 | 17.14 | 17.34 | 17.04 |
Nov-1 | 17.16 | 17.60 | 17.86 | 17.16 |
Nov-4 | 17.62 | 17.76 | 18.10 | 17.44 |
Nov-5 | 18.05 | 18.62 | 18.62 | 17.25 |
Entrada Therapeutics Earnings
Entrada Therapeutics Earnings Report: Per Share Entrada Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Entrada Therapeutics Forecast Revenue Growth
Entrada Therapeutics Stock Analysis: Historical quarterly revenues per share for Entrada Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and a decrease next year of $3.79 per share.
* Entrada Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.